AIM AND SCOPE
The Journal of Cardiology and Vascular Medicine aims to serve as a comprehensive international platform for the publication of high-quality research, clinical studies, and scholarly contributions in the fields of cardiology, cardiovascular sciences, and vascular medicine. The journal is dedicated to advancing scientific understanding of cardiovascular diseases, improving diagnostic and therapeutic methodologies, and promoting the development of innovative treatment strategies for cardiac and vascular disorders. It seeks to bridge the gap between basic cardiovascular research and clinical application by encouraging translational and interdisciplinary studies that contribute to improved patient care, disease prevention, and precision cardiovascular medicine.
The journal also aims to foster collaboration among cardiologists, vascular specialists, researchers, clinicians, academicians, and healthcare professionals worldwide, facilitating the exchange of scientific knowledge and recent advancements in cardiovascular and vascular sciences. Emphasis is placed on scientific rigor, ethical research practices, and the dissemination of findings that have significant clinical, public health, and societal impact in the prevention and management of cardiovascular diseases.
Scope of the journal
The journal covers a wide range of topics within cardiology, cardiovascular sciences, and vascular medicine. The primary areas of interest include, but are not limited to, the following:
Clinical cardiology, preventive cardiology, interventional cardiology, invasive cardiology, non-invasive cardiology, pediatric cardiology, geriatric cardiology, cardiovascular medicine, vascular medicine, cardiovascular surgery, cardiothoracic surgery, cardiac electrophysiology, heart rhythm disorders, cardiac imaging, nuclear cardiology, echocardiography, electrocardiography, cardiovascular pathology, cardiovascular pharmacology, cardiovascular physiology, molecular cardiology, cellular cardiology, translational cardiology, regenerative cardiology, sports cardiology, women’s cardiovascular health, congenital heart disease, ischemic heart disease, coronary artery disease, myocardial infarction, angina pectoris, heart failure, cardiomyopathies, hypertensive heart disease, valvular heart disease, rheumatic heart disease, pericardial diseases, myocarditis, endocarditis, arrhythmias, atrial fibrillation, ventricular tachycardia, sudden cardiac death, pulmonary hypertension, peripheral vascular disease, peripheral artery disease, venous thromboembolism, deep vein thrombosis, aortic aneurysm, aortic dissection, cerebrovascular disease, stroke, carotid artery disease, microvascular disease, endothelial dysfunction, vascular inflammation, atherosclerosis, thrombosis, lipid disorders, dyslipidemia, hypertension, diabetes-related cardiovascular disease, obesity and cardiovascular risk, metabolic syndrome, inflammatory cardiovascular diseases, autoimmune cardiovascular disorders, infectious cardiovascular diseases, cardio-oncology, cardio-metabolic disorders, genetic cardiovascular diseases, inherited arrhythmia syndromes, vascular malformations, lymphatic disorders, vascular aging, and critical care cardiology.
The journal also welcomes research in cardiovascular diagnostics and therapeutic technologies including cardiac biomarkers, molecular diagnostics, genomic cardiology, precision cardiology, personalized cardiovascular medicine, cardiovascular genomics, pharmacogenomics in cardiology, bioinformatics in cardiovascular research, artificial intelligence in cardiology, machine learning in cardiovascular imaging, wearable cardiovascular devices, remote patient monitoring, telecardiology, digital health technologies, biosensors, implantable cardiac devices, pacemakers, defibrillators, ventricular assist devices, extracorporeal membrane oxygenation, catheter-based interventions, coronary angioplasty, stenting procedures, transcatheter valve therapies, minimally invasive cardiovascular procedures, robotic cardiovascular surgery, vascular grafts, tissue engineering, stem cell therapy, regenerative medicine, nanomedicine, targeted cardiovascular therapies, drug discovery, cardiovascular therapeutics, anticoagulant therapy, antiplatelet therapy, thrombolytic therapy, lipid-lowering therapies, immunotherapy in cardiovascular disease, rehabilitation therapies, cardiac rehabilitation, and preventive healthcare strategies.
Additional areas of interest include epidemiology of cardiovascular diseases, cardiovascular public health, community cardiology, population health studies, healthcare disparities in cardiovascular care, environmental and occupational cardiovascular risks, lifestyle medicine, nutrition and cardiovascular health, smoking cessation, physical activity interventions, stress and cardiovascular disease, global burden of cardiovascular diseases, health policy, healthcare management, quality improvement in cardiovascular care, clinical guidelines, evidence-based medicine, patient-centered care, palliative cardiology, healthcare economics, medical education in cardiology, cardiovascular nursing, allied cardiovascular sciences, and multidisciplinary approaches to cardiovascular care.
The journal encourages submissions involving advanced laboratory research and emerging scientific fields such as vascular biology, angiogenesis, endothelial cell biology, smooth muscle biology, oxidative stress, inflammation pathways, signal transduction, cardiac metabolism, mitochondrial dysfunction, proteomics, metabolomics, transcriptomics, systems biology, computational cardiovascular science, multi-omics integration, biomarker discovery, and experimental therapeutics.
Types of Manuscripts
The journal accepts a variety of manuscript types including original research articles, review articles, systematic reviews, meta-analyses, clinical studies, case reports, case series, short communications, technical notes, editorials, perspectives, clinical images, and letters to the editor.
The topics listed above represent the primary areas of interest of the journal; however, the scope is not limited to these main topics. The journal welcomes submissions from emerging, interdisciplinary, and innovative areas that contribute to the understanding, prevention, diagnosis, and treatment of cardiovascular and vascular diseases.
Global Perspective and Inclusivity
The journal adopts a global perspective by encouraging submissions from researchers, clinicians, surgeons, and healthcare professionals across diverse geographic regions. Cardiovascular and vascular diseases remain leading causes of morbidity and mortality worldwide, with variations in prevalence, risk factors, healthcare access, and treatment outcomes across populations.
By promoting international collaboration, the journal seeks to address global cardiovascular health challenges and reduce disparities in diagnosis, prevention, and treatment. Studies highlighting regional epidemiology, population-specific cardiovascular risks, public health initiatives, and healthcare delivery strategies are particularly valuable in expanding global understanding of cardiovascular medicine.
Ethical, Legal, and Social Considerations
Research in cardiology and vascular medicine often involves significant ethical, legal, and social considerations. The journal recognizes the importance of responsible clinical research, patient safety, and ethical healthcare practices.
Topics such as informed consent, patient privacy, data security, equitable healthcare access, ethical clinical trials, responsible use of artificial intelligence, transplantation ethics, and healthcare policy are integral to the journal’s ethical framework. Authors are expected to adhere to established international ethical guidelines and ensure that their research respects patient rights and professional standards.
Education and Knowledge Dissemination
The journal is committed to advancing education and knowledge dissemination in cardiology and vascular medicine. It aims to serve as a valuable resource for students, clinicians, researchers, educators, and allied healthcare professionals by publishing high-quality, informative, and clinically relevant content.
Educational reviews, clinical practice updates, imaging tutorials, procedural guidance, and evidence-based recommendations that simplify complex cardiovascular concepts and support clinical decision-making are strongly encouraged.
Quality, Integrity, and Scientific Rigor
Maintaining high standards of quality, transparency, and scientific integrity is a core principle of the journal. All submissions are expected to demonstrate methodological rigor, clinical relevance, ethical compliance, and clarity of presentation.
The peer review process is designed to ensure unbiased and comprehensive evaluation of submitted manuscripts. Authors are encouraged to present findings transparently and accurately, contributing to the reliability and advancement of cardiovascular scientific literature.
Encouragement of Collaborative Research
The journal promotes collaborative and multidisciplinary research involving cardiologists, vascular specialists, surgeons, radiologists, geneticists, biomedical engineers, public health experts, data scientists, and allied healthcare professionals.
Collaborative studies often provide broader insights into complex cardiovascular conditions and support the development of innovative therapeutic and preventive strategies. National and international collaborative research initiatives are highly encouraged.
Adaptability to Advancing Science
Cardiology and vascular medicine are rapidly evolving fields driven by technological innovation and scientific discovery. The journal remains adaptable to these advancements by continuously expanding its scope to include emerging areas of research and evolving clinical practices.
Authors are encouraged to explore novel concepts, advanced technologies, and future-oriented therapeutic strategies that contribute to improving cardiovascular health outcomes and advancing the field of cardiovascular medicine.
The Journal of Cardiology and Vascular Medicine is committed to promoting excellence in cardiovascular research, clinical practice, and therapeutic innovation by maintaining a broad and inclusive scope. Through multidisciplinary collaboration and dissemination of high-quality scientific knowledge, the journal aims to support medical advancement and improve cardiovascular healthcare outcomes worldwide.
